1. Is the Wegovy® pill FDA-approved for weight loss?
Yes. Novo Nordisk announced FDA approval of Wegovy® pill (once-daily oral semaglutide 25 mg) for weight management in the U.S.
Is the Wegovy® pill the same as the Wegovy® injection?
Both the Wegovy pill and the Wegovy® injection contain the same active ingredient, semaglutide, but the delivery is different.
How do Wegovy® tablets need to be taken?
Wegovy® tablets need to be taken once daily on an empty stomach in the morning with up to 4 ounces of water only. They should be swallowed whole, then wait at least 30 minutes before food, beverages, or other oral medications.
What if a dose is missed?
If a Wegovy® tablet dose is missed, skip it and take the next dose the following day.
What are the most common side effects of Wegovy® pills?
Common side effects of Wegovy® pills can include nausea, diarrhea, vomiting, constipation, abdominal pain, headache, and fatigue.
Who should not take Wegovy®?
Wegovy® is not recommended for patients with a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2.
Can Wegovy® be used during pregnancy?
The FDA label states Wegovy® may cause fetal harm and should be discontinued when pregnancy is recognized for weight reduction or cardiovascular risk reduction. It also advises stopping at least 2 months before a planned pregnancy due to the long half-life.
Is the Wegovy® pill approved for teens?
No. The safety and effectiveness of Wegovy® tablets have not been established in pediatric patients.
Is Wegovy® available as a pill?
Yes, Wegovy® is FDA-approved as a once-daily oral tablet for weight management in eligible adults.
How much does the Wegovy® pill cost?
The cost of Wegovy® pills varies based on insurance coverage, pharmacy pricing, and available savings programs. Exact pricing is confirmed after consultation.
Is Wegovy® going to be in pill form soon?
Wegovy® is already approved and available in pill form following FDA authorization for oral semaglutide.